Employer health plan sponsors and health insurers aren’t able to comply with a requirement that they report detailed drug pricing information to the government later this year.
Three prominent industry groups across the private health insurance sector told the Labor Department that they don’t have all the data needed to report information about prescription drug prices, rebates, and other things that affect consumer and employee premiums and out-of-pocket drug costs.
The comments, due July 23, showcase monumental barriers to complying with a requirement in the Consolidated Appropriations Act (H.R. 133) passed in December 2020 that employer ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.